FR2747691B1 - NUCLEIC ACIDS AND PROTEINS USEFUL AS ANTI-CANCER AND ANTIVIRAL AGENT - Google Patents

NUCLEIC ACIDS AND PROTEINS USEFUL AS ANTI-CANCER AND ANTIVIRAL AGENT

Info

Publication number
FR2747691B1
FR2747691B1 FR9604853A FR9604853A FR2747691B1 FR 2747691 B1 FR2747691 B1 FR 2747691B1 FR 9604853 A FR9604853 A FR 9604853A FR 9604853 A FR9604853 A FR 9604853A FR 2747691 B1 FR2747691 B1 FR 2747691B1
Authority
FR
France
Prior art keywords
cancer
nucleic acids
antiviral agent
proteins useful
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9604853A
Other languages
French (fr)
Other versions
FR2747691A1 (en
Inventor
Robert Amson
Adam Telerman
Daniel Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fondation Jean Dausset-CEPH
Original Assignee
Fondation Jean Dausset-CEPH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9604853A priority Critical patent/FR2747691B1/en
Application filed by Fondation Jean Dausset-CEPH filed Critical Fondation Jean Dausset-CEPH
Priority to CA002240449A priority patent/CA2240449A1/en
Priority to EP96943177A priority patent/EP0868512B9/en
Priority to JP9522549A priority patent/JP2000502893A/en
Priority to AT96943177T priority patent/ATE307886T1/en
Priority to PCT/FR1996/002061 priority patent/WO1997022695A2/en
Priority to DE69635349T priority patent/DE69635349T2/en
Publication of FR2747691A1 publication Critical patent/FR2747691A1/en
Application granted granted Critical
Publication of FR2747691B1 publication Critical patent/FR2747691B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/023—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/028—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a herpesvirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9604853A 1995-12-20 1996-04-18 NUCLEIC ACIDS AND PROTEINS USEFUL AS ANTI-CANCER AND ANTIVIRAL AGENT Expired - Fee Related FR2747691B1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR9604853A FR2747691B1 (en) 1996-04-18 1996-04-18 NUCLEIC ACIDS AND PROTEINS USEFUL AS ANTI-CANCER AND ANTIVIRAL AGENT
EP96943177A EP0868512B9 (en) 1995-12-20 1996-12-20 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer
JP9522549A JP2000502893A (en) 1995-12-20 1996-12-20 Nucleotide sequences, proteins, drugs and diagnostics to treat cancer
AT96943177T ATE307886T1 (en) 1995-12-20 1996-12-20 NUCLEOTIDE SEQUENCES, PROTEINS, MEDICATIONS AND DIAGNOSTIC AGENTS FOR USE IN CANCER TREATMENT
CA002240449A CA2240449A1 (en) 1995-12-20 1996-12-20 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer
PCT/FR1996/002061 WO1997022695A2 (en) 1995-12-20 1996-12-20 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer
DE69635349T DE69635349T2 (en) 1995-12-20 1996-12-20 NUCLEOTIDE SEQUENCES, PROTEINS, MEDICAMENTS AND DIAGNOSIS AGENTS FOR THE USE OF CANCER TREATMENT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9604853A FR2747691B1 (en) 1996-04-18 1996-04-18 NUCLEIC ACIDS AND PROTEINS USEFUL AS ANTI-CANCER AND ANTIVIRAL AGENT

Publications (2)

Publication Number Publication Date
FR2747691A1 FR2747691A1 (en) 1997-10-24
FR2747691B1 true FR2747691B1 (en) 1998-08-28

Family

ID=9491329

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9604853A Expired - Fee Related FR2747691B1 (en) 1995-12-20 1996-04-18 NUCLEIC ACIDS AND PROTEINS USEFUL AS ANTI-CANCER AND ANTIVIRAL AGENT

Country Status (1)

Country Link
FR (1) FR2747691B1 (en)

Also Published As

Publication number Publication date
FR2747691A1 (en) 1997-10-24

Similar Documents

Publication Publication Date Title
CY2007020I1 (en) CERTAIN 5-ALKYL-2-ARYLAMINOPHENYLACETIC ACIDS AND DERIVATIVES
LU91029I2 (en) Interferon conjugates
FI970656A0 (en) Weight regulators, corresponding nucleic acids and proteins and their diagnostic and therapeutic uses
HK1061841A1 (en) Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
MA24307A1 (en) DERIVATIVES OF ARYLSULFONYLAMINO-HYDROXAMIC ACIDS.
FI953837A (en) Synthetic activating amino acids
ATE266383T1 (en) DERMATOLOGICAL PREPARATIONS
DK0991658T3 (en) Dolastatin 15 derivatives
FI952069A0 (en) Low allergenic proteins
IT1291366B1 (en) ANTIVIRAL PHARMACEUTICAL COMPOSITION INCLUDING GLYCYRHIZIC ACID AND AT LEAST ONE PROTEIN WITH ANTIVIRAL ACTIVITY
FR2763953B1 (en) 5'-DESOXY-CYTIDINE DERIVATIVES
FI951101A (en) 5-Vinyl and 5-ethynylquinolone and naphthyridonecarboxylic acids
ITMI941469A0 (en) PROTEINS WITH ANTI-CANCER ACTIVITY
IS4629A (en) Linked viral nucleic acids
DE59603621D1 (en) LEUKOINDIGO PREPARATIONS IN GRANULATE FORM
FR2747691B1 (en) NUCLEIC ACIDS AND PROTEINS USEFUL AS ANTI-CANCER AND ANTIVIRAL AGENT
FI971085A0 (en) New PKA-binding proteins and their uses
DE69524720D1 (en) DERMATOLOGICAL PREPARATIONS
FR2759747B1 (en) STAPLING CLIP
IT1293525B1 (en) BIS-ACRIDINCARBOSSIAMIDI HAVING ANTI-CANCER ACTIVITY
FR2756564B1 (en) QUINOLEINE-8-CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2751970B1 (en) 6,7,8,9-TETRAHYDRO-5H-IMIDAZO [1,2-A] AZEPINE-3-ACETIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
ITFI920146A0 (en) FUNCTIONAL PROTEINS AND THEIR USE FOR THE PREPARATION OF CONJUGATES
ATA114093A (en) MARKED ALPHA AMINO ACIDS
ZA921892B (en) Proteins and nucleic acids

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse

Effective date: 20081231